WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Psychogenic Movement Disorders Global Clinical Trials Review, Q1, 2011

GlobalData, February 2011, Pages: 26

Psychogenic Movement Disorders Global Clinical Trials Review, Q1, 2011

Summary

Our clinical trial report, “Psychogenic Movement Disorders Clinical Trials Review, Q1, 2011" provides data on the Psychogenic Movement Disorders clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Psychogenic Movement Disorders. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade

Reasons to buy

- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies



List of Tables
List of Figures
Introduction
Psychogenic Movement Disorders
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Psychogenic Movement Disorders
Subjects Recruited Over a Period of Time
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
National Institute of Neurological Disorders and Stroke
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
Baylor College of Medicine
Clinical Trial Overview of Baylor College of Medicine
National Institute of Mental Health
Clinical Trial Overview of National Institute of Mental Health
University Hospital Inselspital, Berne
Clinical Trial Overview of University Hospital Inselspital, Berne
University of Florida
Clinical Trial Overview of University of Florida
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Psychogenic Movement Disorders Therapeutics Clinical Trials, Europe, Top Countries, 2011-
Psychogenic Movement Disorders Therapeutics Clinical Trials, North America, Top Countries, 2011-
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011-
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Psychogenic Movement Disorders Therapeutics Market, Global, Suspended Clinical Trials, 2011-
Psychogenic Movement Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Psychogenic Movement Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Psychogenic Movement Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011--
Psychogenic Movement Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011-
Psychogenic Movement Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2011-
Psychogenic Movement Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2011-
Psychogenic Movement Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2011-
Psychogenic Movement Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2011-
Psychogenic Movement Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2011-

List of Figures
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011-
Psychogenic Movement Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Psychogenic Movement Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Psychogenic Movement Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Psychogenic Movement Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011--
Methodology

Customers who bought this item also bought